Dianthus Therapeutics, Inc. /DE/ (DNTH) Marketable Securities, Current USD 2018 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Marketable Securities, Current history and growth rate from 2018 to 2022.
  • Dianthus Therapeutics, Inc. /DE/ Marketable Securities, Current for the quarter ending December 31, 2022 was $54.4 M, a 20.2% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $54.4 M +$9.14 M +20.2% Dec 31, 2022 10-K 2023-03-23
Q3 2022 $69.3 M +$34.2 M +97.4% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $84.6 M +$31.8 M +60.3% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $84.8 M +$1.84 M +2.22% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $45.3 M -$45.4 M -50.1% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $35.1 M +$15 M +74.9% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $52.8 M +$12.6 M +31.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $83 M +$27.5 M +49.6% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $90.7 M +$10 M +12.4% Dec 31, 2020 10-K 2022-03-08
Q3 2020 $20.1 M -$55 M -73.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $40.2 M -$98.9 M -71.1% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $55.5 M -$40.6 M -42.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $80.7 M -$3.57 M -4.24% Dec 31, 2019 10-K 2021-03-03
Q3 2019 $75.1 M Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $139 M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $96.1 M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $84.2 M Dec 31, 2018 10-K 2020-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.